home / stock / pmvp / pmvp message board
Subject | By | Source | When |
---|---|---|---|
2022 American Society of Clinical Oncology (ASCO) Annual Meeting | crudeoil24 | investorshub | 05/27/2022 12:10:26 AM |
JUNE 7 > Updated data from ongoing Phase | crudeoil24 | investorshub | 05/27/2022 12:08:55 AM |
PMV Pharma Shares Rise 17%; Company to Present | crudeoil24 | investorshub | 05/26/2022 11:43:46 PM |
PMV Pharmaceuticals, Inc. is a precision oncology company, | crudeoil24 | investorshub | 05/26/2022 11:42:23 PM |
News, Short Squeeze, Breakout and More Instantly...
PMV Pharmaceuticals Inc. Company Name:
PMVP Stock Symbol:
NASDAQ Market:
2024-04-11 21:15:01 ET Jefferies analyst issues BUY recommendation for PMVP on April 11, 2024 07:46PM ET. PMVP was trading at $1.58 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy recommendations ...
2024-04-11 21:00:03 ET Kambiz Yazdi from Jefferies issued a price target of $5.00 for PMVP on 2024-04-11 19:46:00. The adjusted price target was set to $5.00. At the time of the announcement, PMVP was trading at $1.58. The overall price target consensus is at $31.33 with...
Rezatapopt is a first-in-class precision oncology investigational therapy for patients with advanced solid tumors with a TP53 Y220C mutation and KRAS wild-type (WT) First patient dosed in Phase 2 portion of the PYNNACLE trial which will assess rezatapopt as monotherapy in patients...